West Virginia Oncology Society
The U.S. Food and Drug Administration (FDA) has alerted healthcare professionals not to use
certain intravenous bags of metronidazole, ondansetron, and ciprofloxacin because of potential
contamination.  The FDA has received reports of floating matter in IV bags manufactured by Claris
Lifesciences Limited, in Ahmedabad, India.  Foreign matter should not be present in a sterile
injectable product. Potentially affected products are sold under the Claris, Sagent Pharmaceuticals,
Pfizer, and West-Ward Pharmaceuticals labels. Healthcare professionals should NOT use and
should immediately remove from their pharmacy inventories any metronidazole, ondansetron, and
ciprofloxacin intravenous bags sold under the Claris, Sagent Pharmaceuticals, Pfizer and
West-Ward Pharmaceutical labels.

For additional information as it becomes available, please visit the
FDA website.

Health professionals may report adverse events by using FDA's MedWatch Voluntary Reporting
System.  Information on how to report is available
here.
What's New. . . . .
Contaminated IV Bags of Metronidazole, Ondansetron, and Ciprofloxacin